1st Quarter - Report

DAVIS & HARMAN LLP for EMERGENT BIOSOLUTIONS, INC.

Firm
Client
Income
$10,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

LobbyistCovered position, as disclosed
THOMAS A DAVIS —
CHRIS L GASTON New Chief of Staff, Rep. Rush Holt

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

LobbyistCovered position, as disclosed
THOMAS A DAVIS —
CHRIS L GASTON New Chief of Staff, Rep. Rush Holt

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Homeland Security HOM

FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government. Reauthorization of the Pandemic and All-Hazards Preparedness Act. NDAA - provisions related to biological and chemical defense. Department of Defense appropriations for Medical countermeasures. FDA regulatory issues. Issues related to Priority Review Voucher programs. Opioid and heroin legislation. Naloxone access, coprescribing/opioid prescribing guidelines.

LobbyistCovered position, as disclosed
THOMAS A DAVIS —
CHRIS L GASTON New Chief of Staff, Rep. Rush Holt

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.